Keudell/Morrison Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.98M Buy
4,989
+32
+0.6% +$32.7K 1.13% 19
2026
Q1
$4.56M Sell
4,957
-192
-4% -$195K 0.93% 21
2025
Q4
$5.53M Buy
+5,149
New +$4.92M 1.16% 19
2025
Q2
$4.08M Sell
5,230
-85
-2% -$66.1K 0.9% 20
2025
Q1
$4.39M Buy
5,315
+7
+0.1% +$5.83K 1.04% 20
2024
Q4
$4.1M Buy
5,308
+302
+6% +$250K 1.07% 18
2024
Q3
$4.44M Buy
5,006
+186
+4% +$167K 1.2% 15
2024
Q2
$4.36M Sell
4,820
-141
-3% -$113K 1.28% 15
2024
Q1
$3.86M Buy
4,961
+349
+8% +$248K 1.17% 19
2023
Q4
$2.69M Buy
4,612
+868
+23% +$507K 0.89% 23
2023
Q3
$2.01M Buy
3,744
+81
+2% +$41.7K 0.61% 29
2023
Q2
$1.72M Buy
3,663
+90
+3% +$37.7K 0.5% 35
2023
Q1
$1.23M Buy
3,573
+111
+3% +$37.4K 0.36% 51
2022
Q4
$1.27M Sell
3,462
-194
-5% -$68.8K 0.41% 48
2022
Q3
$1.18M Sell
3,656
-350
-9% -$111K 0.44% 44
2022
Q2
$1.3M Buy
4,006
+20
+0.5% +$6K 0.47% 44
2022
Q1
$1.14M Sell
3,986
-150
-4% -$38.6K 0.48% 54
2021
Q4
$1.14M Sell
4,136
-76
-2% -$19.3K 0.45% 56
2021
Q3
$973K Buy
4,212
+21
+0.5% +$5.18K 0.42% 59
2021
Q2
$962K Hold
4,191
0.53% 57
2021
Q1
$783K Hold
4,191
0.45% 64
2020
Q4
$708K Hold
4,191
0.45% 70
2020
Q3
$620K Sell
4,191
-50
-1% -$7.74K 0.4% 67
2020
Q2
$696K Sell
4,241
-6
-0.1% -$921 0.58% 63
2020
Q1
$589K Buy
4,247
+522
+14% +$71.7K 0.58% 63
2019
Q4
$490K Hold
3,725
0.34% 83
2019
Q3
$417K Hold
3,725
0.34% 86
2019
Q2
$414K Sell
3,725
-500
-12% -$58.9K 0.36% 82
2019
Q1
$548K Buy
+4,225
New +$514K 0.48% 70

Other funds holding LLY

Keudell/Morrison Wealth Management's LLY Position: Q2 2026 in Review

Keudell/Morrison Wealth Management increased its Eli Lilly (LLY) stake by 0.65% in Q2 2026, buying an estimated $32.7K and bringing the position to 4,989 shares worth $5.98M. The position accounts for 1.13% of the portfolio, ranked #19.

Keudell/Morrison Wealth Management first reported a position in LLY in Q1 2019 and has held it in 29 quarters since. 873 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Keudell/Morrison Wealth Management held 4,989 shares of Eli Lilly worth $5.98M as of Q2 2026.
  • Keudell/Morrison Wealth Management bought 32 Eli Lilly shares in Q2 2026, an estimated $32.7K.
  • Eli Lilly made up 1.13% of Keudell/Morrison Wealth Management's portfolio in Q2 2026, its #19 holding.
  • Keudell/Morrison Wealth Management first reported a position in Eli Lilly in Q1 2019 and has held it in 29 quarters since.
  • 873 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Keudell/Morrison Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.